NASDAQ:AFIB Acutus Medical (AFIB) Stock Price, News & Analysis → The Next Nvidia? (From InvestorPlace) (Ad) Free AFIB Stock Alerts $0.12 +0.02 (+19.42%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$0.10▼$0.1550-Day Range$0.11▼$0.2652-Week Range$0.09▼$1.00Volume3.93 million shsAverage Volume1.84 million shsMarket Capitalization$3.66 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Acutus Medical alerts: Email Address Ad The Tomorrow InvestorThe Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest About Acutus Medical Stock (NASDAQ:AFIB)Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.Read More AFIB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AFIB Stock News HeadlinesMay 7, 2024 | msn.comAI Might Boost Detection of A-FibMay 6, 2024 | msn.comApple Watch AFib History Deemed Reliable Enough for Clinical ResearchMay 8, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.May 6, 2024 | investorplace.comWhy Is Acutus Medical (AFIB) Stock Down 41% Today?May 4, 2024 | msn.comYour Apple Watch's AFib history could soon be used in clinical studiesMay 2, 2024 | msn.comApple Watch series AFib monitor getting FDA medical certificationMay 2, 2024 | 9to5mac.comApple Watch AFib feature gets new FDA seal of approvalMay 2, 2024 | appleinsider.comApple Watch is FDA's first-ever approved digital AFib history deviceMay 8, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.April 30, 2024 | msn.comAtrial fibrillation linked to high mortality and hospitalization rates, UQ study showsApril 27, 2024 | investing.comAcutus Medical Inc (AFIB)April 22, 2024 | msn.comUCHealth doctors conduct new atrial fibrillation procedure for first time in ColoradoApril 22, 2024 | msn.comAtrial fibrillation more common and dangerous in younger people than previously thoughtApril 22, 2024 | msn.comA-Fib More Common in Middle-Aged Folk Than ThoughtApril 18, 2024 | msn.comUniversity of Iowa Health Care marks 500th atrial fibrillation treatment procedureApril 18, 2024 | msn.comStudy reveals long-term consequences of atrial fibrillationApril 18, 2024 | msn.comStudy: Heart failure, not stroke, most common complication of atrial fibrillationApril 16, 2024 | msn.comNew procedure to treat atrial fibrillation offered at Baptist Health PaducahApril 15, 2024 | msn.comCirculating biomolecules identify patients with atrial fibrillation at high risk of cardiovascular eventsApril 15, 2024 | msn.comGrand Rapids hospital first in Midwest to use new procedure to treat AFibApril 12, 2024 | msn.comLocal doctor discusses new treatment option for AFibApril 12, 2024 | msn.comPeriodontitis May Modify Risk for Atrial FibrillationApril 12, 2024 | msn.comTreating gum disease during AFib blanking period could reduce recurrence riskApril 10, 2024 | msn.comTreating gum disease after heart rhythm ablation reduces risk of AFib recurrence, study findsApril 9, 2024 | msn.comExperts give recommendations for longer and better lives for patients with atrial fibrillationApril 9, 2024 | msn.comPatients with device-detected atrial fibrillation and multiple comorbidities do not benefit from anticoagulation: StudyApril 8, 2024 | msn.comYOUR HEALTH: Pioneering safe Afib surgerySee More Headlines Receive AFIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today5/07/2024Next Earnings (Estimated)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:AFIB CUSIPN/A CIK1522860 Webwww.acutusmedical.com Phone442-232-6080Fax442-232-6081Employees230Year Founded2011Profitability EPS (Most Recent Fiscal Year)($1.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-81,660,000.00 Net Margins-166.79% Pretax Margin-165.52% Return on Equity-35.31% Return on Assets-13.43% Debt Debt-to-Equity Ratio1.10 Current Ratio2.44 Quick Ratio2.22 Sales & Book Value Annual Sales$7.16 million Price / Sales0.51 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-4.10Miscellaneous Outstanding Shares29,720,000Free Float28,682,000Market Cap$3.66 million OptionableOptionable Beta0.25 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Takeo Mukai (Age 43)CEO & CFO Mr. Gary W. Doherty (Age 58)Senior Vice President of Finance Comp: $434.32kKey CompetitorsSharps TechnologyNASDAQ:STSSG Medical InnovationsNASDAQ:GMVDFAethlon MedicalNASDAQ:AEMDAssureNASDAQ:IONMTenon MedicalNASDAQ:TNONView All Competitors AFIB Stock Analysis - Frequently Asked Questions How have AFIB shares performed in 2024? Acutus Medical's stock was trading at $0.2019 at the beginning of 2024. Since then, AFIB stock has decreased by 39.1% and is now trading at $0.1230. View the best growth stocks for 2024 here. Are investors shorting Acutus Medical? Acutus Medical saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 553,600 shares, a decrease of 34.5% from the March 31st total of 845,200 shares. Based on an average daily trading volume, of 2,250,000 shares, the short-interest ratio is currently 0.2 days. Approximately 2.9% of the company's stock are short sold. View Acutus Medical's Short Interest. When is Acutus Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our AFIB earnings forecast. How were Acutus Medical's earnings last quarter? Acutus Medical, Inc. (NASDAQ:AFIB) released its quarterly earnings results on Thursday, November, 11th. The company reported ($0.94) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The company earned $4.60 million during the quarter, compared to analysts' expectations of $6.02 million. Acutus Medical had a negative trailing twelve-month return on equity of 35.31% and a negative net margin of 166.79%. During the same quarter last year, the business earned ($1.18) earnings per share. What other stocks do shareholders of Acutus Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO). When did Acutus Medical IPO? Acutus Medical (AFIB) raised $126 million in an IPO on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are Acutus Medical's major shareholders? Acutus Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include James F Hinrichs, Orbimed Advisors Llc and R Scott Huennekens. View institutional ownership trends. How do I buy shares of Acutus Medical? Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does Acutus Medical have any subsidiaries? The following companies are subsidiares of Acutus Medical: Acutus Medical N.V..Read More This page (NASDAQ:AFIB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
